Items where Author is " Illés Árpád"

Number of items: 13.

Fésüs Adina and Matuz Mária and Papfalvi Erika Piroska and Hambalek Helga and Ruzsa Roxána and Tánczos Bence and Bácskay Ildikó and Lekli István and Illés Árpád and Benkő Ria: Evaluation of the Diagnosis and Antibiotic Prescription Pattern in Patients Hospitalized with Urinary Tract Infections: Single-Center Study from a University-Affiliated Hospital.
ANTIBIOTICS, 12 (12). ISSN 2079-6382 (2023)

Husi Kata and Szabó Roxána and Pinczés László Imre and Földeák Dóra Melinda and Dudley Réka and Szomor Árpád and Koller Beáta and Gopcsa László and Illés Árpád and Miltényi Zsófia: Improved survival of autologous stem cell transplantation in primary refractory and relapsed Hodgkin lymphoma in the brentuximab vedotin era - real-world data from Hungary.
ANNALS OF HEMATOLOGY, 102 (9). pp. 2555-2563. ISSN 0939-5555 (2023)

Varga Gergely and Tóth András and Szita Virág Réka and Csukly Zoltán and Hardi Apor and Nagy Zsolt and Szaleczky Erika and Schneider Tamás and Kohl Zoltán and Kosztolányi Szabolcs and Alizadeh Hussain and Modok Szabolcs and Borbényi Zita and Lovas Szilvia and Váróczy László and Illés Árpád and Masszi Tamás and Mikala Gábor: Beneficial Effect of Lenalidomide-Dexamethason Treatment in Relapsed/Refractory Multiple Myeloma Patients: Results of Real-Life Data From 11 Hungarian Centers.
PATHOLOGY AND ONCOLOGY RESEARCH, 27. Terjedelem: 6 p-Azonosító: 613264. ISSN 1219-4956 (2021)

Pinczés László Imre and Szabó Roxána and Illés Árpád and Földeák Dóra Melinda and Piukovics Klára and Szomor Árpád and Gopcsa László and Miltényi Zsófia: Real-world efficacy of brentuximab vedotin plus bendamustine as a bridge to autologous hematopoietic stem cell transplantation in primary refractory or relapsed classical Hodgkin lymphoma.
ANNALS OF HEMATOLOGY, 99 (10). pp. 2385-2392. ISSN 0939-5555 (2020)

Gisslinger Heinz and Klade Christoph and Georgiev Pencho and Krochmalczyk Dorota and Gercheva-Kyuchukova Liana and Rossiev Viktor and Dulicek Petr and Illés Árpád and Arpad Pylypenko and Halyna Sivcheva and Lylia Mayer and Egyed Miklós and Borbényi Zita and Masszi Tamás and PROUD-PV Study Group (kollab. közrem.): Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.
LANCET HAEMATOLOGY, 7 (3). e196-e208. ISSN 2352-3026 (2020)

Szász Róbert and Altai Elvira and Pál Katalin and Dombi János Péter and Iványi János and Jakucs János and Jóni Natália and Illés Árpád and Tárkányi Ilona and Szerafin László and Nagy Zsolt and Farkas Péter and Nagy Ágnes and Piukovics Klára and Ujj György and Schneider Tamás: Effectiveness of the Combination of Rituximab and Standard Chemotherapeutic Regimens in Previously Untreated Patients with Chronic Lymphocytic Leukaemia in Real-Life.
PATHOLOGY AND ONCOLOGY RESEARCH, 25 (2). pp. 535-540. ISSN 1219-4956 (2019)

Schneider Tamás and Rosta András and Losonczy Hajna and Radványi Gábor and Ujj György and Egyed Miklós and Illés Árpád and Jakucs János and Szerafin László and Gasztonyi Zoltán and Masszi Tamás and Iványi János and Demeter Judit and Dombi János Péter and Tóth Antal and Borbényi Zita: Efficacy and Tolerability of a 2-Year Rituximab Maintenance Therapy in Patients with Advanced Follicular Lymphoma after Induction of Response with Rituximab-Containing First Line-Regimens (HUSOM Study).
PATHOLOGY AND ONCOLOGY RESEARCH, 24 (2). pp. 199-205. ISSN 1219-4956 (2018)

Molnár Zsuzsanna and Pinczés László Imre and Piukovics Klára and Istenes Ildikó and Wolf Krisztina and Csukly Zoltán and Szomor Árpád and Illés Árpád and Miltényi Zsófia: Relabáló/refrakter Hodgkin-lymphoma brentuximab vedotin kezelése.
ORVOSI HETILAP, 158 (41). pp. 1630-1634. ISSN 0030-6002 (2017)

Garcia-Manero Guillermo and Sekeres Mikkael A. and Egyed Miklós and Breccia Massimo and Graux Carlos and Cavenagh Jamie D. and Salman Huda S. and Illés Árpád and Fénaux Pierre and DeAngelo Daniel J. and Stauder Reinhard and Yee Karen W.L. and Zhu Nancy Y. and Lee Jae-hoon and Borbényi Zita: A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts.
LEUKEMIA, 31. pp. 2799-2806. ISSN 0887-6924 (2017)

Simon Zsófia Zsuzsanna and Marton Imelda and Borbényi Zita and Illés Árpád: Aktualitások a primer myelofibrosis ellátásában [Actualities in the management of primary myelofibrosis].
ORVOSI HETILAP, 157 (39). pp. 1547-1556. ISSN 0030-6002 (2016)

Dimopoulos Meletios A. and Moreau Philippe and Palumbo Antonio and Joshua Douglas and Pour Ludek and Hájek Roman and Facon Thierry and Ludwig Heinz and Masszi Tamás and Kollaborációs szervezet: ENDEAVOR investigators and Horváth Noémi and Egyed Miklós and Masszi Tamás and Szomor Árpád and Borbényi Zita and Illés Árpád and Kovácsovics Tibor (kollab. közrem.): Carfilzomib and dexamethasone versus bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma (ENDEAVOR): a randomised, phase 3, open-label, multicentre study.
LANCET ONCOLOGY, 17 (1). pp. 27-38. ISSN 1470-2045 (2016)

Moskowitz Craig H. and Nademanee Auayporn and Masszi Tamás and Agura Edward and Holowiecki Jerzy and Abidi Muneer H. and Chen Andy I. and Stiff Patrick and Gianni Alessandro M. and Carella Angelo and Osmanov Dzhelil and Kollaborációs szervezet: AETHERA Study Group and Borbényi Zita and Illés Árpád and Masszi Tamás and Szomor Árpád (kollab. közrem.): Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial.
LANCET, 385 (9980). pp. 1853-1862. ISSN 0140-6736 (2015)

Pósfai Éva and Irsai Gábor and Illés Árpád and Méhes Gábor and Marton Imelda and Molnár Csaba and Csípő István and Baráth Sándor and Gergely Lajos: Evaluation of Significance of Lymphocyte Subpopulations and Non-specific Serologic Markers in B-cell Non-Hodgkin's Lymphoma Patients.
PATHOLOGY AND ONCOLOGY RESEARCH, 20 (3). pp. 649-654. ISSN 1219-4956 (2014)

This list was generated on 2024. február 23. 05:30:54 CET.